AIDS

1. MOAR P, Linn K, Premeaux TA, Bowler S, et al
   Plasma Galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
   AIDS. 2024 Apr 12. doi: 10.1097/QAD.0000000000003907.
   

   >> Share

   
   
2. FLORES JM, Moline T, Regan SD, Chen YT, et al
   Neighborhood violent crime exposure is associated with PrEP non-use among black sexually minoritized men and transgender women: A GPS Study.
   AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003906.
   

   >> Share

   
   
3. JANG Y, Kim T, Choi Y, Ahn KH, et al
   Association between obesity and cancer risk in HIV-infected Asians.
   AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003904.
   

   >> Share

   
   
4. OOSTERHOF P, Van Luin M, Brinkman K, Burger DM, et al
   Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen.
   AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003905.
   

   >> Share

   
   
5. GUARALDI G, Milic J, Renzetti S, Motta F, et al
   The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.
   AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003903.
   

   >> Share

   
   
6. SALTO JN, Volkow P, Herrera-Goepfert R, Lopez-Garcia AI, et al
   Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
   AIDS. 2024;38:933-934.
   

   >> Share

   
   

   
   Am J Med

7. SIKORA M, Buontempo MG, Ramachandran V, Knutsen DA, et al
   Eosinophilic Pustular Folliculitis in an HIV-Positive 63-Year-Old Male.
   Am J Med. 2024 Apr 6:S0002-9343(24)00204-3. doi: 10.1016/j.amjmed.2024.
   

   >> Share

   
   
8. SOOD H, Pradhan N, Singh H, Dhibhar DP, et al
   An Unusual Case of Brain Abscess in a HIV Negative Host.
   Am J Med. 2024 Apr 5:S0002-9343(24)00211-0. doi: 10.1016/j.amjmed.2024.
   

   >> Share

   
   

   
   Ann Intern Med

9. LIBMAN H, Krakower D, Taylor JL, Burns RB, et al
   How Would You Manage HIV Pre-exposure Prophylaxis in This Patient With Medical Comorbidities? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2024 Apr 9. doi: 10.7326/M24-0217.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

10. KENGO A, Nabeemeeah F, Denti P, Sabet R, et al
    Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2024 Apr 10:e0158323. doi: 10.1128/aac.01583.
    

    >> Share

    
    
11. CHANDASANA H, Singh R, Adkison K, Ait-Khaled M, et al
    Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1.
    Antimicrob Agents Chemother. 2024 Apr 8:e0150423. doi: 10.1128/aac.01504.
    

    >> Share

    
    

    
    Clin Infect Dis

12. WOHL DA, Koethe JR, Sax PE, McComsey GA, et al
    Antiretrovirals and Weight Change: Weighing the Evidence.
    Clin Infect Dis. 2024 Apr 12:ciae191. doi: 10.1093.
    

    >> Share

    
    
13. DAMAS J, Munting A, Fellay J, Haerry D, et al
    Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV.
    Clin Infect Dis. 2024 Apr 12:ciae189. doi: 10.1093.
    

    >> Share

    
    
14. SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
    COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
    Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
    

    >> Share

    
    
15. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

16. OZHMEGOVA E, Lebedev A, Antonova A, Kuznetsova A, et al
    Prevalence of HIV drug resistance at antiretroviral treatment failure across regions of Russia.
    HIV Med. 2024 Apr 7. doi: 10.1111/hiv.13642.
    

    >> Share

    
    
17. DEMA E, Peters H, Gilleece Y, Thorne C, et al
    Residential and healthcare mobility during pregnancy among women living with HIV in the UK, 2009-2019.
    HIV Med. 2024 Apr 10. doi: 10.1111/hiv.13648.
    

    >> Share

    
    

    
    Int J Cancer

18. DOWNHAM L, Rol ML, Forestier M, Romero P, et al
    Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
    Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

19. RAMBIKI E, Rambiki K, Khalani J, Huwa J, et al
    Letters to the Editor Low Rates of Side Effects in Paclitaxel Chemotherapy for Kaposi Sarcoma and Feasibility of Treatment in Outpatient ART Clinic Settings in Malawi.
    J Acquir Immune Defic Syndr. 2024;96:e1-e2.
    

    >> Share

    
    
20. 
    Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study): Erratum.
    J Acquir Immune Defic Syndr. 2024;96:e3.
    

    >> Share

    
    

    
    Lancet

21. 
    Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    

    >> Share

    
    

    
    Lancet Infect Dis

22. PELUSO MJ, Swank ZN, Goldberg SA, Lu S, et al
    Plasma-based antigen persistence in the post-acute phase of COVID-19.
    Lancet Infect Dis. 2024 Apr 8:S1473-3099(24)00211.
    

    >> Share

    
    

    
    PLoS Med

23. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    

    >> Share

    
    

    
    PLoS One

24. ABRIHAM AA, Shitie E, Melese S, Dessie AM, et al
    Determinants of stillbirth among women who delivered in hospitals of North Wollo Zone, Northeast Ethiopia: A case-control study.
    PLoS One. 2024;19:e0301602.
    

    >> Share

    
    
25. CHEN W, Ma Q, Pan X, Chen L, et al
    Characteristics of men who have casual sex with men among Chinese university students: A cross-sectional study.
    PLoS One. 2024;19:e0301817.
    

    >> Share

    
    
26. GREEN F, du Plooy C, Rehman AM, Nhapi RT, et al
    Language outcomes of preschool children who are HIV-exposed uninfected: An analysis of a South African cohort.
    PLoS One. 2024;19:e0297471.
    

    >> Share

    
    

    
    PLoS Pathog

27. KEELE BF, Okoye AA, Fennessey CM, Varco-Merth B, et al
    Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
    PLoS Pathog. 2024;20:e1012135.
    

    >> Share

    
    
28. WONG RW, Balachandran A, Cheung PK, Cheng R, et al
    Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
    PLoS Pathog. 2024;20:e1012155.
    

    >> Share

    
    

    
    Vaccine

29. CHEUNG DH, Chen S, Fang Y, Sun F, et al
    Influences of mpox disease perceptions, sources and contents of information exposure on mpox vaccine uptake among gay, bisexual, and other men who have sex with men in Hong Kong, China.
    Vaccine. 2024 Mar 12:S0264-410X(24)00259-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
30. YADEGARYNIA D, Keyvanfar A, Keyvani H, Tehrani S, et al
    Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial.
    Vaccine. 2024 Feb 29:S0264-410X(24)00249-4. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
31. PICHON S, Moureau A, Petit C, Kirstein JL, et al
    Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax(R) Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
    Vaccine. 2023 Dec 16:S0264-410X(23)01398-1. doi: 10.1016/j.vaccine.2023.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share